Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04564027
Title A Study Investigating DNA-damage Response Agents in Molecularly Altered Advanced Cancer
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors AstraZeneca
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | FRA | ESP

Facility Status City State Zip Country Details
Research Site Duarte California 91010 United States Details
Research Site Los Angeles California 90089 United States Details
Research Site San Francisco California 94115 United States Details
Research Site Tampa Florida 33612 United States Details
Research Site Indianapolis Indiana 46202 United States Details
Research Site Baltimore Maryland 21231 United States Details
Research Site Ann Arbor Michigan 48109 United States Details
Research Site Saint Paul Minnesota 55102 United States Details
Research Site Las Vegas Nevada 89119 United States Details
Research Site New York New York 10065 United States Details
Research Site Ephrata Pennsylvania 17522 United States Details
Research Site Philadelphia Pennsylvania 19104 United States Details
Research Site Myrtle Beach South Carolina 29572 United States Details
Research Site Bordeaux 33076 France Details
Research Site Dijon 21079 France Details
Research Site Lyon 69373 France Details
Research Site Vandoeuvre les Nancy 54519 France Details
Research Site Barcelona 08036 Spain Details
Research Site Madrid 28050 Spain Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field